The impact of the bladder wall thickness on the outcome of the medical treatment using alpha-blocker of BPH patients with LUTS

Figures & data

Figure 1. Bladder wall thickness <5 mm.

Figure 2. Bladder wall thickness ≥5 mm.

Table 1. Patients’ parameters at baseline.

Parameter	Group 1 (BWT <5 mm) n (59)	Group 2 (BWT ≥5 mm) n (51)	p Value
Age	63 ± 7.2	66 ± 6.8	0.136
Prostate volume	33.1 ± 6.1	35.4 ± 6.3	0.265
PSA	1.45 ± 0.91	1.82 ± 1.3	0.116
IPSS	18.9 ± 3.2	21 ± 4.1	0.005
Voiding score	12.1 ± 3.9	15.6 ± 3.7	0.01
Storage score	8.1 ± 3.2	6.5 ± 3.5	0.041
Postvoid residual	49.1 ± 41.9	62.4 ± 50.3	0.198
Qmax	9.8 ± 3.7	8.6 ± 2.6	0.325
QoL	4.1 ± 0.7	4.5 ± 0.9	0.311

Table 2. Patients’parameters after 2 months of treatment.

Parameter improvement (%)	Group 1 (BWT <5 mm) n (59)	Group 2 (BWT ≥5 mm) n (51)	p Value
IPSS	52.4 ± 19.8	29.8 ± 12.1	0.0001
Voiding score	55.4 ± 20.4	30.1 ± 13.9	0.0001
Storage score	44.7 ± 29.0	22.1 ± 20.3	0.002
Postvoid residual	46.5 ± 34.2	13.1 ± 75.0	0.01
Qmax	69.1 ± 50.9	31.3 ± 32.8	0.0001
QoL	45.5 ± 18.9	25.1 ± 19.1	0.001

Table 3. Patients’ parameters (Prostatic volume – PSA) after 2 months of treatment.

Parameter improvement	Group 1 (BWT <5 mm) n (59)	Group 2 (BWT ≥5 mm) n (51)	p Value
Prostatic volume	31.9 ± 7.4	34.2 ± 6.7	0.196
PSA	1.40 ± 0.81	1.67 ± 1.7	0.211